Muramyl peptides as possible endogenous immunopharmacological mediators.
about
Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis.Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussisBordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathologyBacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesisFree versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.Specific absorption with monoclonal antibodies to muramyl dipeptide of the pyrogenic and somnogenic activities of rabbit monokine.Intracellular sensors of extracellular bacteria.Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.Modulins: a new class of cytokine-inducing, pro-inflammatory bacterial virulence factor.Dissociation between muramyl dipeptide-induced fever and changes in plasma metal levels.Enhancement of dengue virus infection in cultured mouse macrophages by lipophilic derivatives of muramyl peptides.Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.
P2860
Q33603984-97D8C323-0509-408F-90B7-2013978D7D18Q35112080-0066ED26-DB9C-48C4-B65B-3D665FEF8E7DQ36170774-C385B1AE-E557-458B-87DF-D06D73103E4BQ36671660-09DC4288-D021-4331-9C7A-B9EA0F3C8D18Q36953884-22BBA480-D1F7-484E-99C9-2A4DE7977EBFQ37569091-148091D5-95EE-4116-B493-52D8042D23A7Q37925059-052338E5-9FB9-46B5-A30C-10DDACF9647BQ40269295-5638B1CD-421D-486A-8053-B7E753EF17ACQ40471721-54FDDB73-FA69-46FD-8889-647C1D7AB5CDQ40809079-309D3380-2A7F-483E-9967-522C26DF9385Q40820794-63822EE8-E17A-4FBF-B333-1AA48158FA2BQ44748629-4E2976C6-8B34-4349-BDD1-D4C85DAE4771Q46413063-B20F83AB-11F5-487D-9441-368432D5D4C8Q52718664-EFEA18D3-0F97-4210-A878-506F2DE1F991Q53852258-F8265662-6CBE-40D9-8CE4-689199B0D075Q54474084-72F9BCA1-BA64-4ADD-BD6B-62A49152310A
P2860
Muramyl peptides as possible endogenous immunopharmacological mediators.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Muramyl peptides as possible endogenous immunopharmacological mediators.
@en
type
label
Muramyl peptides as possible endogenous immunopharmacological mediators.
@en
prefLabel
Muramyl peptides as possible endogenous immunopharmacological mediators.
@en
P2860
P1476
Muramyl peptides as possible endogenous immunopharmacological mediators.
@en
P2093
P2860
P304
P356
10.1111/J.1348-0421.1983.TB00636.X
P577
1983-01-01T00:00:00Z